In Oymyakon Eyelashes Freeze, Temperatures Sink to -88F


-58 degrees Fahrenheit in Yakutsk, Russia. (sakhalife.ru photo via AP)
-58 degrees Fahrenheit in Yakutsk, Russia. (sakhalife.ru photo via AP)
TT

In Oymyakon Eyelashes Freeze, Temperatures Sink to -88F


-58 degrees Fahrenheit in Yakutsk, Russia. (sakhalife.ru photo via AP)
-58 degrees Fahrenheit in Yakutsk, Russia. (sakhalife.ru photo via AP)

In this remote outpost in Siberia, the cold is no small affair.

Eyelashes freeze, frostbite is a constant danger and cars are usually kept running even when not being used, lest their batteries die in temperatures that average minus-58 degrees Fahrenheit in the winter, according to news reports.

This is Oymyakon, a settlement of some 500 people in Russia’s Yakutia region, that has earned the reputation as the coldest permanently occupied human settlement in the world.

It is not a reputation that has been won easily. Earlier this week, a cold snap sent temperatures plunging toward record lows, with reports as extreme as minus-88 degrees Fahrenheit. The village recorded an all-time low of minus-98 degrees in 2013.

Though schools in the area remain open as temperatures dip into the minus-40s, they were closed on Tuesday, the Associated Press reported.

Dark 21 hours a day in the winter, the town has been an object of international curiosity as its reputation for fearsome cold and the resilient residents who withstand it year after year, has grown.

Amos Chapple, a photojournalist from New Zealand, traveled to the region in 2015 to capture the subzero way of life. The village is remote, located closer to the Arctic Circle than to the nearest major city, some 500 miles away, and Chapple described an arduous trip to get there to The Washington Post. After a seven-hour flight from Moscow, some 3,300 miles away, he took a van to a nearby gas station and then hitched a ride to the village after two days waiting in a shack and living off reindeer soup.

“After the first couple of days I was physically wrecked just from strolling around the streets for a few hours,” he said.

The harsh cold climate permeates nearly every aspect of existence for the people who live in the area.

The winter diet is mostly meat-based, sometimes eaten raw or frozen, due to the inability to grow crops in the frigid temperatures. Some regional specialties include stroganina, which is raw, long-sliced frozen fish; reindeer meat; raw, frozen horse liver, and ice cubes of horse blood with macaroni, according to news reports.

“Yakutians love the cold food, the frozen raw Arctic fish, white salmon, whitefish, frozen raw horse liver, but they are considered to be delicacies,” local Bolot Bochkarev told the Weather Channel. “In daily life, we like eating the soup with meat. The meat is a must. It helps our health much.”

Video taken during the cold snap showed a market, open for business on the snowy tundra, frozen fish standing rigidly upright in buckets and boxes, no refrigeration needed.

Customers in heavy winter clothing walked by, one with a child in tow. The narrator said it was minus-56 degrees.

“Here is the treasure,” the video’s narrator said of the whitefish used to make stroganina. He admitted he was getting a bit cold shooting the video.

“While filming the trading rows my hands froze to wild pain. And sellers stand here all day long. How do they warm themselves?” he said, according to the Siberian Times.

The village was once a stopover in the 1920s and ’30s for reindeer herders who would water their flocks at a thermal spring that didn’t freeze. Bathrooms are mostly outhouses; the ground is too frozen for pipes. According to the Weather Channel, the ground has to be warmed with a bonfire to break into, such as for digging a grave.

According to the Siberian Times, two men died after their car stalled and they had set out on foot during the cold streak. The group, a horse breeder and four friends, had gone to check on some animals near the river.

The press office for the region’s governor said that all households and businesses have central heating and backup power generators, according to the Associated Press.

After his trip, Chapple said it was not easy doing man-on-the-street interviews in a place that was so cold, as people outside rushed quickly from one warm place to another. Alcoholism is believed to be an issue in the area, Chapple told reporters. Depending on how cold the weather dips, people often trade off 20-minute shifts when doing work outside, according to news reports.

Chapple said saliva would freeze into “needles that would prick my lips.” Shooting was no easier — his camera would constantly get too cold to shoot, he said. The steam escaping his mouth would “swirl around like cigar smoke” he told Wired, so he’d have to hold his breath so it didn’t cloud the frame. He told Wired that he shot one photo without his gloves only to find his thumb partially frozen.


The Washington Post



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”